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Lymphocytes bear many types of surface molecules, some of which are re- 
stricted to subpopulations of lymphocytes and may be necessary for their spe- 
cialized immune functions. Examples of such antigens include: the Ia antigens; 
cell surface immunoglobulin; the Fc receptor, complement (C) receptors, and Ly- 
4 all present predominantly on B lymphocytes and Thy (theta) antigen; and 
sheep erythrocyte  receptor, and the Ly-1, 2, and 3 antigens all present on T cells. 
H antigens (H-2 or HL-A) and ~-microglobulin are found on all populations on 
lymphocytes. Because a non-H-2, B-lymphocyte-specific  antigen had been sero- 
logically defined on the murine lymphoblast line L1210 (reference i and footnote 
1) and because a  similar human, non-HL-A antigen could be present on the 
human B-lymphoblast line IM-1, from which the isolation of the HL-A antigen 
was in progress, attention has been paid to the "contaminant" molecules of the 
HL-A antigen preparations/ 
Several cell surface antigens have been identified, one of which (p23,30) is 
similar to Ia antigens which have been described on mouse B lymphocytes. The 
purification of that antigen, its distribution on distinct subsets of human lym- 
phocytes, and the properties of heteroantisera to p23,30 in lymphocyte func- 
tional assays are described in this and the accompanying paper (3). 
Materials and Methods 
Alloantisera.  AUoantisera BC (anti-HL-A3), DAL (anti-HL-A27), and WMS (anti-W28) were 
gifts from Dr. D. Bernard Amos, Duke University, Durham, N. C. BEL (anti-HL-A27) was the gift 
of Dr. Thomas Fuller, Harvard Medical School, Boston, Mass. Several alloantisera which were 
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i Humphreys, R. E., A. Ahmed, R. E. Budd, K. W. Sell, and W. E. Vannier. 1976. Identification 
of a  B lymphocyte-specific alloantigen on the L1210 lymphoblast cell line. Manuscript submitted 
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Aarhus, Denmark (2). 
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obtained from multiparous women of an Amish population, were found to histotype for an HL-A. 
linked alloantigen present only on B lymphocytes (4, 5). These sera are listed in Table II. 
Heteroantisera.  Antisera to the p23,30  complex were raised by injection of 25 ~tg of the antigen 
(material identical to that in gel C of Fig. 1) in 0.01 M Tris buffer, pH 8.0, homogenized with an 
equal volume of Freund's complete adjuvant (Difco Laboratories, Detroit, Mich.) into the foot pads 
of a rabbit. One subcutaneous booster injection at 6 wk was made with 25 ~g of soluble antigen in 
saline. Antisera raised from four rabbits were not significantly different in cytotoxic titers or in 
precipitin patterns. Antiserum to p12 (~2-microglobulin)  was prepared by R. Robb, Harvard 
University, Cambridge, Mass., by injection  of  100 ~g of  purified  ~-microglobulin (the  gift  of  Dr. 
M. D. Poulik, Wayne State University, Detroit,  Mich.) in saline  solution  and Freund's complete 
adjuvant into  the foot  pads of  a rabbit.  Booster injections  with 100-pg portions of  saline-eoluble 
antigen were given at  two 6-wk intervals,  after  which the animal was exsanguinated. 
Heat-Aggregated IgG.  Heat-aggregated IgG was prepared by heating a 2 ml/ml solution of 
human IgG (Worthington Biochemical Corp.,  Freehold, N. J.)  in  phosphate-buffered saline  at  63°C 
for  30 rain.  Large aggregates were removed by centrifugation  at 3,000  g for 20 min. 
Separation of  B, T, and Null Lymphocytes from Peripheral Blood.  Highly purified  populations 
ofT, B,  and Null cells  were isolated  by methods which have  been described in  detail  previously (6, 
7). In brief,  human mononuclear cells  were obtained from Ficoll-Hypaque  separated peripheral 
blood (8).  These cells  were washed in medium 199 containing 5% fetal  calf  serum and 2.5 mM 
EDTA, and then passed through a Sephadex G-200 antihuman Fab column. The effluent  cell 
population (nonretained) contained <2% cells  bearing  surface  Ig  and 70-85% of  these cells  formed 
spontaneous rosettes  with  sheep erythrocytes (RBC's) (E  rosettes)  (7).  This  population was defined 
as  the  T plus Null  population.  In  contrast,  the  lymphocytes which bound to  the  immunoabsorbent 
column and which were subsequently recovered by elution  with soluble  immunoglobulin (10  mg/ 
ml) were >97%  surface immunoglobulin  positive and >98%  E-rosette negative. These cells 
represent the B-cell  population. The nonimmunoglobulin-boaring population (T plus Null) was 
depleted of  T cells  by the formation and subsequent removal by Ficoll-Hypaque sedimentation of 
E-rosetting  cells  (7).  The nonrosetted cells  which were recovered at the interface  were immuno- 
globulin negative and E-rosette  negative.  This population was depleted of  EAC-rosetting cells  by 
Ficoll-Hypaque sedimentation, leaving at  the interface  a population of  EAC-negative Null cells. 
Highly purified  T cells  were isolated  from the T plus Null preparation by the formation and 
subsequent depletion of EAC-rosetting cells.  The cells  recovered after  this separation were 
immunoglobulin negative but more than 92% formed spontaneous E rosettes  (7). 
Separation of  B Lymphocytes by  Adherence in  a Microtiter  Plate.  Microtiter  plates  were coated 
with trinitrobenzene sulfonate (TNP), washed, and antisera to TNP was added. After 30 min of 
incubation at  37°C,  the  plates  were washed and  human peripheral  blood lymphocytes, obtained  by 
Ficoll-Hypaque gradient centrifugation (8),  were added to  each well of  a second microtiter  plate. 
Cytotoxic antisera (5 ~l)  were added to  each well and incubated for  30  min at  37°C.  After washing 
these cells,  5 ~l of  normal rabbit  serum was added as  a source of  C and the  plates  were incubated 
for 1 h at room temperature.  A trypan blue solution  containing 1.4% EDTA  was added and cell 
death was scored by light  microscopy. This procedure was used for  results  presented in Tables I 
and If. 
~Cr-Release  Cytotoxic Assays.  The 5~Cr-release microtiter plate  cytotexic assay  of antisera 
and the cytotexic inhibition assay of antigen was based on established techniques (9-12).  One unit 
of antigen activity was that amount required to reduce the percentage chromium release from 90 
to 50% with a  given, diluted antiserum under the conditions of this assay. 
Antibody Absorptions by Platelets.  Washed platelets  (blood  groups O, Rh  +)  were suspended at 
10  ~°  platelets/ml  and diluted 1:2 serially  in dextrose-gelatin-veronal  buffer  (DGV).  3  Aliquots of 
platelets  (25 pl)  were incubated for  i  h at  4°C with 25-~I  aliquots  of(a) 1:50  diluted  anti-p23,30  or 
(b) 1:25  diluted  anti-~ microglobulin serum in microtiter  plates  following a previously described 
absorption technique (13).  After absorption,  the plates  were centrifuged and 5-~I aliquots  of  the 
3  Abbreviations used in this paper: DGV, dextrose-gelatin-veronal buffer; MLC, mixed lympho- 
cyte culture; NP-40, Nonidet P-40; NITS, normal rabbit serum; PBL, peripheral blood lymphocyte; 
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supernate were assayed for the presence of cytotoxic antibodies against peripheral blood lympho- 
cytes (PBL's). 
Internal Labeling and Double Antibody Precipitation of Antigens.  [35S]methionine was pre- 
pared  by  hydrolysis  of Escherichia coli which  had  been grown  on  a  sulfate-limited  minimal 
medium and fed [35S]sulfate (14). Lymphoblast cells (2 ×  10e/ml) were grown overnight in a limited 
medium composed of four parts methionine-free RPMI 1640 medium and one part spent culture 
medium, and 1-5 mCi 35S-labeled E. coli hydrolysate. These internally labeled cells were washed 
in 0.01 M Tris buffer, pH 8.0, containing 0.14 M NaC1, solubilized in 0.15% Nonidet P-40 detergent 
(Shell Chemical Corp., New York) in the same buffer, and centrifuged at 100,000 g  for 1 h. Aliquots 
of the supernatant solution (500 ~1) were incubated for 4 h with a rabbit heteroantisera, followed 
by an overnight incubation with goat antirabbit IgG serum.  The precipitates were washed and 
dissolved in sodium dodecyl sulfate  (SDS) gel loading buffer without reduction. Aliquots of the 
precipitates were electrophoresed. The gels were fixed, sliced longitudinally, and dried. Autoradi- 
ograms  of the  gels  were  scanned  on  a  Joyce-Loebl  densitemeter  (Joyce,  Loebl  &  Co.,  Inc., 
Burlington, Mass. ). 
Antibody-Binding Assay.  An assay for the blocking of binding to lymphoblasts of a radioiodi- 
nated (second) antibody by previously incubating lymphoblasts with serial dilutions of an unla- 
beled (first) antiserum has been adapted to microtiter plates. IM-1 cells (2 ×  103 in 5 pl of DGV) 
(Grand Island Biological Co.,  Grand Island, N.  Y.) were incubated at 4°C with 5 ftl of blocking 
unlabeled antiserum, serially diluted in DVG for 1 h. 5 ~l of a second, radioiodinated IgG fraction 
of antibody was added for a second 1 h  incubation at 4°C. The IgG fraction had been prepared by 
Na2SO4  precipitation and dialysis (15) and was radioiodinated by the chloramine-T method (16). 
The cells were washed three times with 100-/~1 aliquots of DGV and the cells were transferred from 
the well to a  15 x 125 mm plastic tube. The radioiodine bound to the cells in this tube was counted 
in a gamma counter. Results are plotted as counts of radioiodine on labeled antibody bound to the 
cells as a  function of the dilution of unlabeled blocking antiserum. 
Mixed Lymphocyte Culture Assay.  Standard one-way mixed lymphocyte cultures (MLC) were 
established by the method of Hartzman et al. in fiat-bottomed microtiter plates (Falcon Plastics, 
Div. of BioQuest, Oxnard, Calif.) using triplicate wells, each containing 0.2 x  l0  s responding cells 
and 0.2 x  106 stimulating cells which had been pretreated with 50 ~g/ml ofmitomycin-C for 30 min 
at 37°C and then washed three times (17). All cultures were established in '~final medium" (Media 
199 containing 1% penicillin-streptomycin, 200 mM L-glutamine, 25 mM HEPES buffer, and 0.5% 
NaHCO3;  Microbiological Associates,  Bethesda,  Md.)  supplemented with 20% heat-inactivated 
human AB serum.  In addition, in some cultures 0.1 ml of normal rabbit serum  (NRS) or anti- 
p23,30 were added in final dilution of 1/20 and 1/100. After 5 days the cells were pulsed with 0.2/~Ci 
of [3H]thymidine (sp act 1.9 Ci/mmol, Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, 
N. J.) and harvested 16 h  later with a  MASH II apparatus (Microbiological Associates). Radioac- 
tivity was measured  in  a  Packard  liquid scintillation counter  (Packard  Instrument Co.,  Inc., 
Downers Grove, Ill.), and the results of triplicate wells expressed as counts per minute _+ standard 
error of the mean. 
Results 
Preparation of the p23,30 Antigen.  This polypeptide complex was separated 
from HL-A antigen at a  late stage of preparation.  The purification of papain- 
solubilized  HL-A  antigen  from the  cell  line  RPMI 4265  has already  been  de- 
scribed (18).  Briefly,  in the present study membranes of the IM-1 cell line were 
digested with dithiothreitol  (DTT)-preactivated papain under nonreducing con- 
ditions. 4 After centrifugation at 100,000 g  for 1 h, the supernatant solution was 
passed onto a  DEAE-cellulose  column in 0.01  M Tris-HC1 buffer,  pH 8.0,  and 
HL-A  antigen-containing  material  was  eluted  with  0.3  M  NaC1  in the  same 
buffer. The eluant was concentrated and applied to a  Bio-Gel A-15m gel filtra- 
tion column (Bio-Rad Laboratories, Richmond, Calif.) in 0.01 M Tris-HC1 buffer, 
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FIG.  i.  SDS-polyacrylamide  gels  run in  Tris-bicine  buffer.  The materials used were from 
the experiment of  Fig. 2. (A) HL.A antigen prepared with DTT-preactivated papain con- 
tarninated with other  cell  surface antigens  (the  material  applied to the gel filtration 
column, Fig. 2). (B) The 70,000  dalton glycoprotein. (C) The complex of  30,000 and 23,000 
dalton subunits. (D) HL-A antigen with polypeptides at  35,000 and 12,000  daltons. 
pH 8.0. Fractions of  column effluent containing HL-A antigens were applied to a 
second DEAE-cellulose column in 0.01 M Tris-HC1 buffer, pH 8.0, and eluted 
with a linear gradient of NaC1 between 0 and 0.2 M, in the same buffer. The HL- 
A  antigen-containing peak was pooled and concentrated. An SDS pelyacryl- 
amide gel electrophoresis pattern of this material is shown in tube A of Fig. 1. 
This material was passed onto a  1.5  x  110 cm Sephadex G-150 gel filtration 
column in 0.01 M Tris-HCl buffer, pH 8.0. The absorbance profile at 280 nm of 
fractions of this column is shown in Fig. 2, as is the profile of HL-A cytotoxic 
inhibitory units. SDS gels of material from the three largest peaks are shown in 
gels B, C, and D, respectively (Fig.  1). 
Molecular  Weight  and Subunit Composition.  The G-150 column was cali- 
brated with the dimethylsuberimidate  dimer of bovine serum albumin, ovalbu- 
rain, lysozyme, and [14C]glycine. Peak B material, p70, eluted at an apparent 
tool wt of 70-80,000 daltons. Peak C material, which eluted from the Sephadex 
column at an apparent size of 50-70,000 daltons, showed in SDS gels two bands 
at 23,000 and 30,000 daltons. For convenience, this complex of peptides will be 
referred to as p23,30. 
Antisera to p23,30.  Antisera to p23,30 was prepared in four rabbits. Precipi- 
tant arcs in Ouchterlony gels between these sera and p23,30 did not show any 
cross-reaction with purified HL-A antigen (gel D, Fig. 1); with p70 (gel B, Fig. 
1);  with  /32-microglobulin  (gift of Dr.  Poulik);  with orosomucoid (gift of Dr. 
Jeanloz, Harvard Medical School); or with p13.5, a B-cell-specific protein which 
is distinct from fl~-microglobulin.  No cross-reaction with antisera to various 
immunoglobulins (IgG, M, A, D, and E) (Meloy Laboratories Inc., Springfield, 
Va. and Cappel Laboratories, Inc., Downingtown, Pa.) or to haptoglobin (Meloy 
Laboratories Inc.) was found. Cytotoxic assays of these four sera against PBL's 
from several individuals and IM-1 lymphoblasts gave similar patterns with each 
serum. However, lyric patterns of these four sera against purified T-,  B-, and 102  HUMAN  B-CELL  ANTIGEN 
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FIG. 2.  Sephadex G-150 gel  filtration  of  the antigen preparation shown in gel  A of  Fig. 1. 
The 70,000  dalton dimer (B),  the 23,000  and 30,000  daltons complex (C),  and the HL-A 
antigen  (D) are resolved. Cytotoxic inhibitory units determined with anti-HL-A3  (BC) 
human alloantiserum are shown. MW,  molecular weight. 
Null-lymphocyte  populations  showed that one rabbit had absolutely no C- 
dependent lysis  ofT cells  at 1:1  dilution,  while a 1:2,000  titer  against B cells  was 
obtained. The studies reported here are with one antiserum. The other three 
rabbit antisera reacted with T cells  to a lysis  titer  of 1:4-1:16  while showing a 
1:2,000  titer  against B lymphocytes. 
Lysis of Purified Cell Populations  with Anti-p23,30  Serum and with HL-A 
Typing Sera and Anti-t~-Microglobulin.  Cytotoxic titration of various cell 
populations with anti-p23,30  is shown in Fig. 3.28% of RH-PBL's were lysed to 
an end point of 1:2,000, in a plateau pattern indicating that a subpopulation of 
PBL's was lysed. Study of the lysis of separated T  and B PBL's of 46  other 
individuals showed that only B lymphocytes  were lysed at high titer. The lysis of 
purified lymphocyte  subpopulations from one individual was examined in detail 
(Fig. 3). Complete lysis of B cells and no lysis ofT lymphocytes  was observed. In 
contrast, only 15-20% of the purified Null-cell population was lysed. Lysis of the 
Null-cell population also occurred in plateau fashion, suggesting that only a 
subpopulation of Null cells expressed p23,30. Further experiments showed that 
anti-p23,30  serum lysed that portion of Null cells which bear the EAC receptor. 
Removal of the subpopulation of Null cells which formed EAC rosettes elimi- 
nated reactivity with anti-p23,30  serum, while a repeated E-rosetting procedure 
(which removed contaminating T cells) did not reduce the percentage of Null 
cells lysed. 
The RH-1 and IM-1 lymphoblast lines were completely lysed by anti-p23,30 HUMPHREYS  ET  AL.  103 
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FIG. 3.  Lysis of peripheral blood lymphoeytes and purified T, B, and Null cells (from RH) 
and of two lymphoblast lines (RH-1 and IM-1) with anti-p23,30  serum. 
serum  to  a  titer  of  1:2,000  (Fig.  3).  Several  continuous  B-  and  T-cultured 
lymphoblast lines were examined  (Table I). All four B-cell lines were lysed at 
high titer.  No reaction was observed with two of the T-cell lines. Some reaction 
was  seen  with  the  third  T-cell  line  (HSB)  (19)  but  only  at  a  high  antibody 
concentration.  In  contrast  to the  lytic pattern  observed with  the  anti-p23,30 
serum, all subpopulations of lymphocytes (T, B, and Null) were lysed by a first 
HL-A  locus antiserum  (BC,  anti-HL-A3),  by a  second HL-A  locus antiserum 
(DAL,  anti-HL-A27),  and by rabbit anti-fl~-microglobulin  serum.  Fig.  4 illus- 
trates the lytic pattern with anti-fl2-microglobulin serum. The patterns with BC 
and DAL sera were similar with 50% lytic end points of 1:125 and 1:32, respec- 
tively. 
Absence ofp23,30 from Platelets.  Under conditions at which 4  ×  108 plate- 
lets/ml  absorbed 50%  of the cytotoxic activity of anti-fl2  microglobulin  serum 
(1:25 dilution),  100  ×  108 platelets had no effect in absorbing anti-p23,30 serum 
(1:100  dilution).  Under  conditions  of this  assay  p23,30  antigen  could  not  be 
detected on human platelets. 
Cytotoxic Inhibitory Assay with Anti-p23,30 Serum.  A cytotoxic inhibitory 
assay using a  1:800 dilution  of anti-p23,30  was used to follow the presence of 
p23,30 antigen in a  preparation of cell surface antigens which were solubilized 
from  IM-1  cells  by  cysteine-activated  papain.  The  absorbance  tracing,  and 
cytotoxic inhibitory units  of p23,30 and of three  HL-A antigen  specificities in 
fractions  of a  Sephadex  G-150  column  are  presented  in  Fig.  5.  SDS  gels  of 
fractions of these columns  (Fig.  6) showed bands at 23,000 and 30,000  daltons 104  HUMAN  B-CELL  ANTIGEN 
TABLE  I 
Lysis of B- and T-cell-Cultured Lymphoblasts by Anti-p23,30 
Serum 
B- or T-cell char- 
Cell line  Lysis  Dilution  -j 
acter 
% 
SB  B  100  500 
HSB  T  60  20 
8392  B  100  500 
8402  T  0  10 
PA3  B  100  500 
CEM  T  0  10 
4265  B  100  500 
I00--  ~RH-I 
"~  Lysis by  /\.~_ \ 
Anti- p12  l~x~PBL,  s 
e  / 
0-- 
,  I  ,  1  ,  I  ,  I 
16  :>50  4000  Abe 
Antiserum  Dilution -I 
Fro. 4.  Lysis  of PBL's;  purified T, B, and Null cells; and two lymphoblast  lines (RH-1 and 
IM-1) by rabbit anti-~2-microglobulin serum. 
corresponding to the occurrence of anti-p23,30 cytotoxic inhibitory activity (i.e., 
fractions 53-63).  Likewise, the fractions which contained the 35,000 and 12,000 
dalton bands of HL-A antigen corresponded to those which had HL-A cytotoxic 
inhibitory activity (i.e., fractions 60-70).  These patterns are similar to those of 
Fig.  1 in which the p23,30  complex eluted from the gel filtration column at a 
higher molecular weight than the HL-A antigen complex of a glycopeptide and 
fl2-microglobulin. 
Size  of the  Detergent-Solubilized  Antigen  which  is  Precipitated  by  Anti- 
p23,30.  Cells labeled with  [35S]methionine were solubilized in Nonidet P-40 HUMPHREYS  ET  AL. 
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FIG.  5.  Sephadex G-150 gel filtration ofpapain-released cell surface proteins from the IM- 
1 lymphoblast cell membranes. 
105 
FIG. 6.  Polyacrylamide gels  (SDS  in  Tris-bicine) of the  Sephadex  G-150 gel filtration 
column of Fig. 5. The p23,30 antigen complex is in fractions 56 and 60. HL-A glycopeptide 
and/~-microglobulin are most clearly seen in fractions 64 and 68 corresponding to the peak 
of HL-A cytotoxic inhibitory activity. MW, molecular weight. 
(NP-40). Az~ter high speed centrifugation, the supernatant solution was treated 
with  rabbit  anti-p23,30  serum or  with  a  rabbit  anti-/32-microglobulin serum 
followed by goat antirabbit IgG serum ("sandwich precipitation") and the precip- 
itates were subjected to SDS gel electrophoresis. The anti-pl2 (/32-microglobulin) 
serum precipitated two peptides of 44,000  and  12,000 daltons. The anti-p23,30 106  HUMAN  B-CELL  ANTIGEN 
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Fro.  7.  psS]methionine  internally labeled and NP-40-solubilized membranes were copre- 
cipitated with anti-p23,30 and  anti-pl2 (B2-microglobulin), respectively. Densitometer 
scans of autoradiograms  of SDS-polyacrylamide  gels of  these precipitates show three peaks 
of detergent-solubilized  antigen bound to anti-p23,30 and two peaks bound to the anti-fl2- 
microglobulin antiserum (the HL-A antigen glycopeptide  and/~2-microglobulin). 
serum precipitated three polypeptides of 39,000, 34,000, and 29,000 daltons (Fig. 
7). 
Precipitation  with Anti-HL-A  Typing Sera.  Similar antibody precipitates 
with histotyping alloantisera were made from NP-40-solubilized,  [35S]methio- 
nine-labeled cells. Each pattern showed a dominant labeled material at 44,000 
daltons (the glycoprotein of HL-A antigen) (Fig. 8). The/~2-microglobulin com- 
ponent of HL-A antigen at 12,000 daltons is best seen in the DAL (anti-HL-A27) 
pattern. In each pattern, materials in the 30,000-40,000  dalton range were also 
precipitated. These materials may correspond to the materials precipitated by 
anti-p23,30  serum  (Fig.  7).  BEL  antiserum also  precipitated another larger 
material in the molecular weight range of p70  (cf. Fig. 1). 
Relationship of HL-A and p23,30 Antigens on the Cell Surface.  The rela- 
tionship of p23,30 and the glycoprotein chain of HL-A antigen on the surface of 
IM-1  lymphoblasts  may be judged  to  some  extent  by  competitive  blocking 
experiments with antisera against these antigens. Anti-p23,30  serum gave a 
50%  inhibition end  point  of 1:64 in  blocking the  subsequent binding  of the 
radioiodinated gamma globulin fraction of anti-p23,30  serum  (Fig.  9).  Under HUMPHREYS  ET  AL. 
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FIG.  8.  Double antibody coprecipitates of HL-A and other alloantigens of the RH-1 cell 
line, formed  with histotyping alloantisera. Note the high molecular weight alloantigen 
recognized by BEL antiserum. 
identical conditions anti-p35 serum (raised against the papain-solubilized glyco- 
protein  chain  of HL-A  antigen)  gave  a  parallel  inhibition  curve  with  a  50% 
blocking titer of 1:16. Minimal blocking was seen with anti-pl2 serum (directed 
against  fl~-microglobulin).  No blocking was seen with anti-p70  serum or with 
heat-aggregated  human IgG. 
In similar experiments,  unlabeled anti-pl2  serum inhibited the subsequent 
binding of a radioiodinated gamma globulin fraction of anti-pl2 serum with a 
50% inhibition end point at a titer of about 1:64. Anti-p23,30 and anti-p35 sera 108  HUMAN  B-CELL  ANTIGEN 
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FIG.  9.  The binding of radioiedinated anti-p23,30  to IM-1 cells is blocked by previously 
incubating the  cells  with  anti-p35  (the  glycopeptide  of HL-A  antigen) and partly by 
preincubation of the cells with anti-pl2 (~2-microglobulin). Preincubation  with heat-aggre- 
gated (AGG) IgG or anti-p70 had no effect. The heat-aggregated IgG was serially diluted 
from a 2 mg/ml solution. 
blocked the binding of anti-p12 serum with titer of about 1:4. Minimal blocking 
was seen with anti-p70 serum and no blocking was seen with heat-aggregated 
IgG. These experiments suggest the possibility that the p35,12 complex (HL-A 
antigen) and p23,30 complex may be close to each other on the cell surface. 
Inhibition of Amish Antisera by p23,30 Antigen.  Several Amish alloanti- 
sera have been described which recognize a  non-HL-A,  B-cell-specific human 
alloantigen  (6).  Several HL-A homozygous cell lines have been established in 
continuous cell culture from Amish  individuals  and  have been found to bear 
antigens recognized by some of these sera. Purified p23,30 antigen from the IM-1 
cell line  (material  shown in gel C of Fig.  1) and p23,30 containing  portions of 
papain-solubilized antigens from the cell lines RPMI-4265 and JY were tested as 
inhibitors of cytolysis of the Amish cell lines by the Amish alloantisera  (Table 
II).  The  following points  may  be  noted:  (a)  JY  antigen  inhibited  all  of the 
antisera  when the target  cells were homologous  (JY or PY cells); 6 out of 10 
antisera  were inhibited  when the  target  cells were the other two Amish  cell 
lines (KL and SL). The four remaining antisera  (177, 359, 590, and MAB) were 
inhibited only when the target cells  (JY and PY) and the p23,30 antigen  (JY) 
were  homologous.  (b)  Sera  35  and  289  were  similar  and  were  inhibited  by 
antigen  from IM-1  cells but  not by antigen  from 4265  cells.  By contrast  the 
reverse was true from serum 76. (c) Serum RMB was inhibited by all three of the 
p23,30 antigens.  It must recognize a  common determinant  on these antigens. 
These  observations  are  consistent  with  the  possibility  either  that  the  three 
p23,30 antigens from IM-1, RPM1 4265,  or JY cells are alloantigen alleles at a HUMPHREYS  ET  AL.  109 
TABLE  II 
Inhibition by p23,30 Antigens of Amish Cell Lines by Amish Antisera 
Amish  Cell  source  of 
cell  line  p23,30  added 
Amish antiserum 
35  76  124  177  192  289  359  590  MAB  RMB 
KL  IM-1  +  ....  +  -  -  -  + 
RPMI  4265  -  +  .......  + 
JY  +  +  +  -  +  +  -  _  _  + 
SL  IM-1  +  ........  + 
RPMI  4265  -  +  .......  + 
JY  +  +  +  -  +  +  -  _  _  + 
PY  IM-1  +  ....  +  -  -  -  + 
RPMI  4265  +  +  .......  + 
JY  +  +  +  +  +  +  +  +  +  + 
JY  IM-1  +  .... +  -  -  -  + 
RPMI  4265  -  +  .......  + 
JY  +  +  +  +  +  +  +  +  +  + 
The  antisera  were obtained  from  multiparous  women of  the  Indiana  Amish community and  define 
non-HL-A antigens  represented  on B lymphocytes (5,  6).  The B-cell  lines  were established  from 
four  individuals  of  the same community by transformation  with  Epstein-Barr  virus  and were 
labeled  with [51Cr]sodium  chromate.  The  antigens  (100  ~g/ml)  were used  as  inhibitors  of  cytolysis 
at  a 1:5  dilution  in  a  chromium-release  assay.  +,  inhibition  of  40%  or  greater  and  was  most  often  in 
the  range  of  60-70%. -, inhibition  of  20% or  less  and was most often  in  the  range  of  5-15%. 
TABLE  III 
Inhibition of Mixed Lymphocyte  Cultures  by Anti-p23,30 
Mixed cul- 
Media controls 
tures* 
Normal rabbit serums  Rabbit anti-p23,30* 
1/20  dilution  I/I00  dilution  1/20  dilution  1/100  dilution 
Exp.  1  XXm  548  -- 36  1,334  _+ 81  855  ±  574  561  ±  59  819  ±  68 
XY  m  73,084  ±  4,371  73,557  -+ 9,987  82,887  ±  18,330  4,590  ±  1,962  12,370  -+ 2,422 
Exp.  2  XXm  601  ±  36  549  ±  196  4,761  ±  902  1,542  ±  591  4,892  ±  666 
XYm  88,675  -+ 4,693  79,815  -+  11,743  73,365  ±  9,361  5,926  ±  620  3,612  -*  110 
* One-way mixed cultures were established using responding  lymphocytes from individual X and stimulating  cells  from an allogeneic 
individual Y. The subscript m  implies mitomycin-treated  populations. 
~t  Cultures were established  for  6 days at 37°C in  a 96% CO2-5% air  atmosphere in  the presence of  either  media, NRS, or varying dilutions  of 
anti-p23,30. [3H]thymidine  incorporation was measured at day 6. 
single locus or that the p23,30 antigen in each case arises from at least two 
genetic loci,  or both. 
Inhibition of MLC  by Anti-p23,30.  Several  of the  above  findings  were 
consistent with the view that p23,30 antigen is the human  analog of  murine Ia 
antigens: the molecular weight of  the detergent product, the cellular distribu- 
tion of the antigen, and inhibition  of Amish  sera which recognize an HL-A- 
linked B-cell alloantigen.  Since murine anti-la serum is known to inhibit MLC 
reactivity it was therefore important to determine the effect of anti-p23,30 on 
human  MLC  assays. Standard one-way MLC's were established in the presence 
of  either anti-p23,30 serum, NRS, or media controls. The presence of  anti-p23,30 
serum during the 5-day culture period markedly reduced and in some instances 
totally eliminated MLC  reactivity (Table III).  In contrast, NRS  had no signifi- 110  HUMAN  B-CELL  ANTIGEN 
cant effect. In other experiments we attempted to see whether the inhibition of 
MLC by anti-p23,30 was observed aider precoating either responding or stimu- 
lating  cells.  Thus,  stimulating  or responding cells were pretreated  with anti- 
p23,30 or NRS, washed, and then placed in mixed cultures.  Under these condi- 
tions no significant reduction in MLC was seen. Whether the lack of inhibition 
under these pretreatment  conditions is secondary to the rapid turnover of cell 
membranes during culture or alternatively whether sufficient anti-p23,30  was 
washed free from the cell surface before culture has not been resolved. The same 
phenomena has been observed with murine anti-Ia sera. 
Discussion 
p23,30 is a  unique,  B-lymphocyte-specific cell surface protein complex.  It is 
immunochemically  different  from  previously  identified  membrane  antigens; 
including immunoglobulins,  HL-A antigen,  and fl~-microglobulin. The antigen 
is restricted to B lymphocytes and to a subpopulation of Null lymphocytes which 
bear a  receptor for C. The antigen  is not found on T  lymphocytes, C-receptor- 
negative Null lymphocytes, or platelets. The distribution on nucleated cells has 
been followed by cytotoxic and immunofluorescence assays at both low and high 
titers of antiserum.  The lack of reactivity of this unabsorbed heteroantiserum 
with cell populations not bearing p23,30 antigen has been striking and under- 
lines the value of this approach  in the study of membrane  antigens,  i.e.,  the 
preparation  of antisera against purified proteins. 
Because many structural  and  functional  characteristics  of this  antigen  are 
very similar  to  those  of the  murine  Ia  antigen,  one  may  view this  antigen 
complex to be the human  counterpart  of the murine  Ia antigen.  The antigen 
complex p23,30 resembles murine Ia antigens in four ways: (a) chemical struc- 
ture, (b) tissue distribution, (c) linkage to the major histocompatibility complex, 
and (d) biological function as judged by effects of antisera to p23,30 in various 
systems.  The detergent-solubilized form of the papain-derived  p23,30 antigen 
was identified in SDS-polyacrylamide gels of double antibody-precipitated,  ra- 
diolabeled antigen.  This  native  antigen  resembles the  structure  of mouse Ia 
antigens  which have been reported by others  (20-22),  although  three  compo- 
nents  were resolved in  the  human  antigen.  Several human  histotyping  sera 
precipitated  molecules of weights  similar  to the native,  detergent-solubilized 
precursor  of p23,30.  These  sera  presumbly  recognized  alloantigenic  determi- 
nants on the p23,30 antigen.  Cytotoxic Amish alloantisera  which recognize an 
HL-A-linked B-cell alloantigen were inhibited by p23,30 antigen.  The genes for 
the p23,30 antigen appear to be linked to the major histocompatibility complex, 
as are genes for Ia antigens.  It should be noted that  antibodies with  similar 
specificity to p23,30 antibody have been described in pregnancy sera  (23,  24). 
These  antisera  also inhibit  the  MLC  reaction  and  react  predominantly  with 
human  B  cells but not T  cells.  In  contrast to anti-p23,30  antibody,  however, 
these antibodies seem to react with antigenic structures  on lymphocyte mem- 
branes of mol wt 11,000  daltons  (fl2-microglobulin) and 50-45,000 daltons  (23). 
Whether the p23,30 membrane antigen complex, which is present on all B cells, 
is the common determinant recognized by these B-cell alloantisera remains to be 
defined.  Others  have  also reported  on the  existence  of Ia-like  human  B-cell 
antigens  (25, 26).  Finally, it is of interest that both the B-cell-specific alloanti- HUMPHREYS  ET  AL.  111 
sera and anti-p23,30 serum in addition recognize antigens on non-T-cell leuke- 
mias (27, 28). 
Summary 
In addition to HL-A antigens, another cell surface protein complex has been 
obtained from membranes  of the  human  B-lymphoblast cell line  IM-1.  This 
complex which was solubilized with papain, consisted of polypeptides of 23,000 
and 30,000 daltons (p23,30).  Rabbit antisera to this material precipitated from 
[35S]methionine-labeled  detergent-solubilized cells,  three  proteins  of 39,000, 
34,000,  and  29,000  daltons.  These  antisera  were  specifically cytotoxic for  B 
lymphocytes of peripheral blood,  for B-lymphoblast cell  lines,  and  for EAC 
rosette  receptor-positive surface  Ig-negative  (Null)  lymphocytes. The  p23,30 
complex was not present on T lymphocytes, EAC rosette receptor-negative Null 
lymphocytes, or platelets. In addition, the p23,30 complex from several cell lines 
inhibited alloantisera from multiparous Amish women which had been shown to 
recognize non-HL-A, B-lymphocyte antigens. Some other properties of the anti- 
p23,30 sera antisera were described. 
Received for publication 27 January 1976. 
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